ET
Electra Therapeutics, Inc.
SEC filingBiotechnology · South San Francisco, CA
Amount raised$134.2Msold at filing
Total offering$184.1M$49.9M still open
Investors in the raise19count reported to the SEC
FiledOct 30, 2025first sale Oct 15, 2025
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Beth Seidenberg, M.D.Director
Thomas Geninatti, Ph.D.Director
Matthew FustDirector
Carl Gordon, Ph.D.Director
Nancy Stagliano, Ph.D.Director
Quehuong (Kathy) Dong, Pharm.D.Executive Officer, Director
Executive officers, directors and promoters as listed on the Form D.